This trial is conducted globally. The aim of this trial is to investigate dose-finding of semaglutide administered subcutaneously once daily versus placebo and liraglutide in subjects with type 2 diab

NIAID Data Ecosystem50

Predictors of exposure, therapeutic and adverse effects of certolizumab pegol, baricitinib and tocilizumab used in the treatment of rheumatoid arthritis.

类风湿性关节炎药物研究

副作用预测

Rheumatoid arthritis (RA) is the most common auto-immune inflammatory disease in adults. The World Health Organization estimates more than 23 million people live with rheumatoid arthritis; this consti

DataCite Commons2025-08-12 更新20

Available IPD datapackage for study 'An Open-Label Study to Assess the Effects of BG00012 on Lymphocyte Subsets in Subjects With Relapsing-Remitting Multiple Sclerosis'

多发性硬化症药物疗效

白细胞亚群分析

The primary objective of the study is to evaluate the effect of BG00012 on lymphocyte subset counts during the first year of treatment in subjects with relapsing-remitting multiple sclerosis (RRMS).

DataCite Commons2025-04-19 更新10

Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes

资源简介：

Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes

资源简介：

相关数据集